WWTR1 and chronic myelogenous leukemia, BCR-ABL1 positive: Thus, we were surprised to find aberrant expression of TAZ, but not YAP, in CML cells resistant to both first and second generation TKIs in vitro (Fig. 2D-F), as well as in BP-CML patients compared to those in CP or AP (Fig. 2G and H).